| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.51 | 0.08 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.24 | 1e-06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.13 | 0.7 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |